Healthcare resource utilization and costs of cardiovascular events in patients with atherosclerotic cardiovascular disease in Germany – results of a claims database study-Reference-Cited by-同舟云学术

Healthcare resource utilization and costs of cardiovascular events in patients with atherosclerotic cardiovascular disease in Germany – results of a claims database study

Published:2022-11-21 Issue:1 Volume:25 Page:1199-1206
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Sidelnikov Eduard¹,Dornstauder Eugen²,Jacob Christian³,Maas Christopher³,Pinto Lionel⁴,Leidl Reiner⁵,Ahrens Ingo⁶

Affiliation:

1. Global Value & Access, AMGEN (Europe) GmbH, Rotkreuz, Switzerland

2. Health Economics and Outcomes Research, AMGEN GmbH (Germany), München, Germany

3. EU Real World Evidence, Xcenda GmbH, Hanover, Germany

4. Global Health Economics, Amgen Inc, Thousand Oaks, CA, USA

5. Institute for Health Economics and Healthcare Management, Ludwig-Maximilians-Universität München, München, Germany

6. Klinik für Kardiologie und internistische Intensivmedizin, Krankenhaus der Augustinerinnen – Severinsklösterchen, Köln, Germany

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2141964

Reference32 articles.

1. Deutsche Herzstiftung e.V. Deutscher Herzbericht 2019. 2019.

2. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany

3. Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors

4. High Blood Pressure and Cardiovascular Disease

5. Prevalence and Incidence of Hypertension in the General Adult Population

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determining Cost-Saving Risk Thresholds for Statin Use;2024-08-20

2. Trends in direct health care costs among US adults with atherosclerotic cardiovascular disease with and without diabetes;Cardiovascular Diabetology;2024-07-08

3. Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study;European Heart Journal - Quality of Care and Clinical Outcomes;2024-07-01

4. Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide;Acta Oncologica;2024-04-09

5. Prevention by Heat Stimulation of Metabolic Syndrome Progression Based upon the Underlying Molecular Mechanism;Metabolic Syndrome - Lifestyle and Biological Risk Factors [Working Title];2024-04-05